Activities of arabinosyladenine monophosphate and 9-(1,3-dihydroxy-2-propoxymethyl)guanine against ground squirrel hepatitis virus in vivo as determined by reduction in serum virion-associated DNA polymerase

Antimicrob Agents Chemother. 1985 Feb;27(2):277-9. doi: 10.1128/AAC.27.2.277.

Abstract

Treatment of chronic ground squirrel hepatitis virus infection with arabinosyladenine monophosphate at 20 mg/kg per day for 3 weeks caused marked decreases in serum virion-associated DNA polymerase concentrations in three of five squirrels. Statistically significant but less dramatic decreases in enzymatic activity were noted in two of six squirrels treated with 50 mg of 9-(1,3-dihydroxy-2-propoxymethyl)guanine per kg per day. After therapy, DNA polymerase activities rose to pretreatment levels.

MeSH terms

  • Acyclovir / analogs & derivatives*
  • Acyclovir / pharmacology
  • Acyclovir / therapeutic use
  • Animals
  • Antiviral Agents / pharmacology*
  • Antiviral Agents / therapeutic use
  • Arabinonucleotides / pharmacology*
  • DNA-Directed DNA Polymerase / blood*
  • Ganciclovir
  • Hepatitis Viruses / drug effects*
  • Hepatitis Viruses / enzymology
  • Hepatitis, Viral, Animal / drug therapy*
  • Hepatitis, Viral, Animal / microbiology
  • Liver / enzymology
  • Sciuridae / microbiology*
  • Vidarabine Phosphate / pharmacology*
  • Vidarabine Phosphate / therapeutic use
  • Virion / enzymology

Substances

  • Antiviral Agents
  • Arabinonucleotides
  • Vidarabine Phosphate
  • DNA-Directed DNA Polymerase
  • Ganciclovir
  • Acyclovir